Cell–cell interaction networks regulate blood stem and progenitor cell fateDaniel C. Kirouac, Peter W. Zandstra, Gerard J. Madlambayan et al.|Molecular Systems Biology|2009Cited by 125
Targeting the MTF2–MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to ChemotherapyHarinad B. Maganti, William L. Stanford, Hani Jrade et al.|Cancer Discovery|2018Cited by 57
Clinically Relevant Expansion of Hematopoietic Stem Cells with Conserved Function in a Single-Use, Closed-System BioprocessGerard J. Madlambayan, Peter W. Zandstra, Ian M. Rogers et al.|Transplantation and Cellular Therapy|2006Cited by 47
Evaluating dose-limiting toxicities of MDM2 inhibitors in patients with solid organ and hematologic malignancies: A systematic review of the literatureL. Pi, Grace Christou, Jasjit Rooprai et al.|Leukemia Research|2019Cited by 24
The AC133+CD38−, but not the rhodamine-low, phenotype tracks LTC-IC and SRC function in human cord blood ex vivo expansion culturesCaryn Y. Ito, Peter W. Zandstra, Daniel C. Kirouac et al.|Blood|2009Cited by 15